Release of targeted p53 from the mitochondrion as an early signal during mitochondrial dysfunction

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• The tumor suppressor protein p53 accumulates in response to cellular stress.
• The role of p53 sequestered within mitochondria remains largely unexplored.
• Mitochondrial dysfunction is implicated in various diseases.

Purpose of the Study:

• To investigate the fate and signaling capacity of mitochondrially localized p53.
• To elucidate the pathway of p53 translocation from mitochondria to the nucleus.
• To explore potential therapeutic targets modulating p53 mitochondrial localization.

Main Methods:

• Transfection of p53-EGFP fusion proteins with mitochondrial import signals into p53-deficient mouse embryonic fibroblast cells.
• Induction of mitochondrial stress using rotenone.
• Analysis of p53 post-translational modifications (phosphorylation and acetylation) in mitochondria and nucleus.
• Pharmacological inhibition using PK11195, a TSPO ligand.

Main Results:

• Rotenone exposure induced the translocation of mitochondrially targeted p53-EGFP from mitochondria to the nucleus.
• Recombinant p53 exhibited distinct post-translational modifications in the nucleus versus the mitochondria.
• PK11195 partially inhibited the release of mitochondrially sequestered p53.
• These findings suggest a direct mitochondrial-nucleus signaling axis for p53.

Conclusions:

• Mitochondrial p53 can translocate to the nucleus, establishing a signaling pathway during mitochondrial dysfunction.
• Post-translational modifications differ between nuclear and mitochondrial p53.
• Targeting mitochondrial TSPO may modulate p53 signaling in mitochondrial stress responses.